http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2440807-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc27e2b221d6517b7fd21efadec4c3a1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-04
filingDate 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c8ceee249a03e39d9ccd05708ab93ee
publicationDate 2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2440807-C1
titleOfInvention Method of treating and increasing quality of patients with gallbladder dyskinesia
abstract FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to gastroenterology, physiotherapy, rexlexotherapy. Method includes carrying out drug therapy. Additionally, taking into account degree of expression of anxiety-depressive disorders by Hamilton scale data, antidepressant asaphen is introduced. In case of clinically expressed disorders asaphen is introduced in dose 75 mg per day, in case of subclinically expressed affective disorders - in dose 50 mg per day. Intake of asaphen is realised during 30 days. Taking into account individual peculiarities of vegetative balance state magnetic laser puncture is performed. For this purpose used is wavelength 1.3 mcm, modulated mode, frequency 2.4 Hz, magnetic-acupuncture nozzle 50 mT. Impact is carried out during 10-30 s per one biologically active point. In case of sympathicotonia point Gl 4 is sedated and points E 25, E 36, MC 6 are toned up. In case of vagotonia point Gl 4 is toned up and points E 25, E 36, MC 6 are sedated. Course includes 10-12 procedures. ^ EFFECT: method increases patients' life quality, reduces treatment terms, increases remission duration, reducing number of recurrences due to correction of state of day chronobiorhythms, psychoemotional sphere and vegetative balance. ^ 2 ex, 2 tbl
priorityDate 2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454735462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159976
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451796451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 23.